Growth Metrics

Veracyte (VCYT) EPS (Basic) (2016 - 2026)

Veracyte's EPS (Basic) history spans 14 years, with the latest figure at $0.52 for Q4 2025.

  • On a quarterly basis, EPS (Basic) rose 642.86% to $0.52 in Q4 2025 year-over-year; TTM through Dec 2025 was $0.84, a 162.5% increase, with the full-year FY2025 number at $0.84, up 162.5% from a year prior.
  • EPS (Basic) hit $0.52 in Q4 2025 for Veracyte, up from $0.24 in the prior quarter.
  • Over the last five years, EPS (Basic) for VCYT hit a ceiling of $0.52 in Q4 2025 and a floor of -$0.66 in Q1 2021.
  • Historically, EPS (Basic) has averaged -$0.07 across 5 years, with a median of -$0.12 in 2023.
  • Biggest five-year swings in EPS (Basic): tumbled 660.0% in 2023 and later soared 642.86% in 2025.
  • Tracing VCYT's EPS (Basic) over 5 years: stood at -$0.14 in 2021, then soared by 64.29% to -$0.05 in 2022, then tumbled by 660.0% to -$0.38 in 2023, then surged by 118.42% to $0.07 in 2024, then soared by 642.86% to $0.52 in 2025.
  • Business Quant data shows EPS (Basic) for VCYT at $0.52 in Q4 2025, $0.24 in Q3 2025, and -$0.01 in Q2 2025.